World Class Candidate
Hematology and Oncology Research NP
Executive Summary & Candidate Overview
- Doctorate-prepared nurse practitioner with 10+ years of clinical experience in rare hematology, oncology, and stem cell transplants (SCT)/gene therapies
(including hemophilia and sickle cell disease) at 4 academic centers of excellence. - Supported/s 30+ clinical trials (Phases 1-4) and the launch of 3 targeted therapies at a single institution.
- Leading 3 investigator-sponsored research (ISR) studies to advance the impact of 2 products (e.g. monoclonal antibody and genomic ctDNA testing) and provide real world evidence (RWE). Presenting these studies at an international congress for rare diseases in May 2023.
- Successfully launched new/expanding HCP teams with innovative initiatives, including creating a novel onboarding program, training & mentoring 25+
NPs/PAs, and developing SOPs. - Supports KOLs in medical care of infants to young adults with rare hematology and oncology diagnoses; and continually builds network of KOLS through
national/international organizations. - Background includes leading cross-functional collaborations, protocol development, creating initiatives to improve workflows, comfortably delivering
presentations (live, virtual, written), easily communicating (live, virtual, email, phone) with KOLS using conversational scientific style, and working remotely. - Collaborating with Kellogg MBA program at Northwestern University to identify and develop relationships with local healthcare industry leaders (including
founders and C-suite execs) to develop business acumen.
Accomplishments and KPIs
Research and Publications:
ISR PRINCIPAL INVESTIGATOR | CHLA | United Therapeutics | Actively enrolling
“RAPID Pilot Study Evaluating Feasibility of Rapidly Infusing Dinutuximab” (NCT05421897)
Skills: Protocol development, clinical trial design, CRF development, database management, CRA management, stakeholder alignment, multidisciplinary collaboration, cross-functional collaborations, scientific and clinical education.
CHILDREN’S ONCOLOGY GROUP PROTOCOL NURSE | Active Member
- Responsibilities & accountabilities
- Support clinical trial team in study design, methodology, data analysis, endpoint definitions, and interpretation.
- Support medical content strategy by developing clinical study reports, annual reports, scientific/clinical education, and updates to be disseminated to KOLs and stakeholders on national/international levels.
- Serve as resource to provide clinical support (e.g. answering responsive requests from investigators, ensuring effective coordination, and support patient recruitment/retention) to HCPs as point-person for multiple clinical trial sites across the US.
- Prioritizes patient-centric communications and deliverables by incorporating health literacy and cultural awareness principles.
ISR INVESTIGATOR
- United Therapeutics | Manuscript pending “Institutional Review and Recommendations of Chemoimmunotherapy Treatment in High Risk Neuroblastoma Patients” (CHLA-22-00115)
- Foundation Medicine| Manuscript pending “Utilization of Liquid Biopsy to Identify Genomic Alterations for Pediatric High Risk Neuroblastoma” (CHLA-20-00304)
PRESENTATIONS
- Advances in Neuroblastoma Research (ANR) international congress (Publication in May 2023)
- “Utilization of Liquid Biopsy to Identify Genomic Alterations for Pediatric High Risk Neuroblastoma”
- “Characterizing Chemoimmunotherapy Response in Patients with ALK-mutated Relapsed or Refractory Neuroblastoma”
Skills, Experience, Depth of External Relationships
ANN & ROBERT LURIE CHILDREN’S HOSPITAL OF CHICAGO Chicago, IL 2022 – Present
Hematology/Oncology/SCT NP| Center for Cancer and Blood Disorders | Division of Cellular Therapy
CHILDREN’S HOSPITAL OF LOS ANGELES (CHLA) Los Angeles, CA 2018-2022
Lead Oncology Nurse Practitioner | Cancer and Blood Disease Institute
SEATTLE CHILDREN’S HOSPITAL Seattle, WA 2013-2018
Lead Nurse Practitioner Surgical Hospitalist | Division of Hospital Medicine
PENN STATE HERSHEY CHILDREN’S HOSPITAL Hershey, PA 2012 – 2013
Registered Nurse | Pediatric Hematology/Oncology/SCT unit | Penn State Cancer Center
Education & Certifications:
Doctorate in Nursing Practice | GPA: 3.9 | Dean’s List
The University of Arizona, Tucson, AZ
Bachelor of Science in Nursing | GPA: 3.9 | Honor’s Distinction | Dean’s List
Cum Laude | Sigma Theta Kappa
The University of Arizona, Tucson, AZ
EXPERT RESOURCE
- Kellogg Business Healthcare Conference (2022-present)
- Established and nurtured partnerships with healthcare industry leaders to participate in the conference.
- Led the development of workshops and medical forums to support strategic discussions on disrupting and advancing healthcare innovations.
- Helped with operational planning
- United Therapeutics (2020-2022)
- Provided drug administration insights and acted as resource to other institutions
- Provided insights for the development of patient and parent education deliverables
LICENSES & CERTIFICATIONS
- Active IL NP, certified by Pediatric Nursing Certification Board for Primary Care (PNCB-PC)
- Certified Pediatric Hematology Oncology Nurse (CPHON) – Oncology Nursing Certification Corporation
- Certified Pediatric Chemotherapy and Biotherapy Provider– Association of Pediatric Hematology/Oncology Nurses (APHON)
- Biomedical Research Investigators and Key Personnel – CITI Program
- Healthcare Strategy Course (Professor Garthwaite)– Kellogg School of Management, Northwestern University 2023
Position Seeking: Medical affairs as a Medical Science Liaison and impact patients on a larger scale by supporting biopharmaceutical innovations.
Current Position: DNP, APRN, CPHON
Current Location: Chicago, IL
Compensation Seeking: $160,000-$200,000
